ReWalk Robotics Ltd.

Equities

LFWD

IL0011331076

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 25/06/2024 BST			5-day change	1st Jan Change
4.07 ^USD	-0.49%		-3.33%	-25.24%

05-16	HC Wainwright Adjusts Price Target on ReWalk Robotics to $13 From $9, Maintains Buy Rating	MT
05-15	Transcript : ReWalk Robotics Ltd., Q1 2024 Earnings Call, May 15, 2024

ReWalk Robotics Ltd. Announces the Resignation of Wayne B. Weisman from Audit Committee

January 13, 2016 at 09:44 pm

ReWalk Robotics Ltd. announced that Mr. Wayne B. Weisman resigned from the Company's audit committee effective January 12, 2016. Mr. Weisman will remain a member of the Company's board of directors. Mr. Kalish, 58, serves as general counsel and partner at OurCrowd Management Limited.

Latest news about ReWalk Robotics Ltd.

HC Wainwright Adjusts Price Target on ReWalk Robotics to $13 From $9, Maintains Buy Rating	05-16	MT
Transcript : ReWalk Robotics Ltd., Q1 2024 Earnings Call, May 15, 2024	05-15
Earnings Flash (LFWD) REWALK ROBOTICS (DBA LIFEWARD) Reports Q1 Adjusted Loss $-0.62, vs. Street Est of Adjusted EPS $-0.70	05-15	MT
Earnings Flash (LFWD) REWALK ROBOTICS (DBA LIFEWARD) Reports Q1 Revenue $5.3M, vs. Street Est of $5.6M	05-15	MT
ReWalk Robotics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
ReWalk Robotics Ltd. Provides Financial Guidance for the Second Quarter and Full Year of 2024	05-15	CI
ReWalk Robotics Ltd. Appoints Mike Swinford to the Board of Directors	04-19	CI
Lifeward, CMS Working to Finalize Exoskeleton Medicare Payment Rate, CEO Says	04-01	MT
ReWalk Robotics Set to Complete 1-for-7 Reverse Split of Ordinary Stock	03-13	MT
ReWalk Robotics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI
Transcript : ReWalk Robotics Ltd., Q4 2023 Earnings Call, Feb 27, 2024	02-27
Rewalk Robotics Ltd. Provides Earnings Guidance for the Full Year and First Quarter of 2024	02-27	CI
Earnings Flash (LFWD) REWALK ROBOTICS Reports Q4 Revenue $6.9M	02-27	MT
ReWalk Robotics Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-27	CI
ReWalk Robotics Ltd.(NasdaqCM:LFWD) added to NASDAQ Composite Index	01-30	CI
ReWalk Robotics Ltd. will Change its Name to Lifeward	01-30	CI
ReWalk Robotics Ltd. will Change its Ticker to LFWD from RWLK	01-30	CI
ReWalk Robotics Ltd.(NasdaqCM:LFWD) dropped from NASDAQ Composite Index	01-29	CI
ReWalk Robotics Expands Direct Sales to Canada; Shares Rise	01-12	MT
ReWalk Robotics Says It Successfully Demonstrates Exoskeleton Prototype	11-28	MT
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype	11-28	CI
ReWalk Robotics Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Transcript : ReWalk Robotics Ltd., Q3 2023 Earnings Call, Nov 14, 2023	11-14
Earnings Flash (RWLK) REWALK ROBOTICS Reports Q3 Revenue $4.4M	11-14	MT
Transcript : ReWalk Robotics Ltd. - Special Call	11-08

Chart ReWalk Robotics Ltd.

Duration

Period

More charts

Company Profile

ReWalk Robotics Ltd. doing business as Lifeward is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.

Sector

Medical Equipment, Supplies & Distribution

Calendar

06/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for ReWalk Robotics Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.07 USD

Average target price

10.75 USD

Spread / Average Target

+164.13%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
REWALK ROBOTICS LTD.	-25.24%	35.01M
STRAUMANN HOLDING AG	-19.32%	19.5B
COCHLEAR LIMITED	+9.76%	14.46B
DEMANT A/S	+4.19%	9.64B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-23.62%	1.9B
EMBLA MEDICAL HF.	+2.37%	1.72B
ANGELALIGN TECHNOLOGY INC.	+0.35%	1.24B
MODERN DENTAL GROUP LIMITED	+2.56%	525M
ANGEL ROBOTICS CO., LTD.	0.00%	372M
DELCATH SYSTEMS, INC.	+99.76%	231M

Medical Prosthetics